Prophylix AS is a Norwegian biotech company developing orphan drugs for the prevention of life-threatening or chronically disabling intracranial bleeding in fetuses due to fetal and neonatal alloimmune thrombocytopenia (FNAIT). The lead drug NAITgam contains specific IgG antibodies derived from plasma donated by women with a history of FNAIT in their fetus or newborn. The NAITgam is developed within the frames of the EU-supported PROFNAIT project, read more at: www.profnait.eu
| Website | http://www.prophylix.com |
| Revenue | $6 million |
| Employees | 1 (1 on RocketReach) |
| Founded | 2008 |
| Address | Sykehusveien 23, Tromsø, Troms 9019, NO |
| Phone | +47 95 11 23 85 |
| Technologies | |
| Industry | Biotechnology Research, Manufacturing General, Biotechnology, Manufacturing, Drug Discovery |
| Keywords | Orphan Drugs, Rare Disease Treatment, Platelet Disorders, Biotech, Drug Development, Pregnancy Complications, Pharmaceutical, Hematology, Immunology, Clinical Trials |
| Competitors | Zywave, Ренессанс Жизнь, Страховая компания, Wellness Corporate Solutions, LLC, Catasys Inc., Teladoc Health, MDLIVE, by Evernorth, Anthem Health Plans, Inc., LifeWorks (acquise par TELUS Santé | acquired by TELUS Health), Optum, Bupa Global +31 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Prophylix AS employee's phone or email?
Prophylix AS Questions
The Prophylix AS annual revenue was $6 million in 2026.
1 people are employed at Prophylix AS.
Prophylix AS is based in Tromsø, Troms.
The NAICS codes for Prophylix AS are [32, 325, 3254].
The SIC codes for Prophylix AS are [28, 80, 283].
Related Companies
